Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cannabinoids and PPARalpha signalling.

Y Sun1, S P H Alexander, D A Kendall

  • 1School of Biomedical Sciences, University of Nottingham, Nottingham NG7 2UH, UK. stxys3@nottingham.ac.uk

Biochemical Society Transactions
|November 1, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular expression patterns in the synovium and their association with advanced symptomatic knee osteoarthritis.

Osteoarthritis and cartilage·2019
Same author

Coronary artery hypoxic vasorelaxation is augmented by perivascular adipose tissue through a mechanism involving hydrogen sulphide and cystathionine-β-synthase.

Acta physiologica (Oxford, England)·2018
Same author

A critical role for cystathionine-β-synthase in hydrogen sulfide-mediated hypoxic relaxation of the coronary artery.

Vascular pharmacology·2017
Same author

Effects of the March 2015 solar eclipse on near-surface atmospheric electricity.

Philosophical transactions. Series A, Mathematical, physical, and engineering sciences·2016
Same author

A semiconductor photon-sorter.

Nature nanotechnology·2016
Same author

The anti-NGF antibody muMab 911 both prevents and reverses pain behaviour and subchondral osteoclast numbers in a rat model of osteoarthritis pain.

Osteoarthritis and cartilage·2016
Same journal

TDP-43 proteinopathy as a biomarker and therapeutic target in amyotrophic lateral sclerosis.

Biochemical Society transactions·2026
Same journal

Advancing the monitoring of organelle contact sites in vitro and in vivo.

Biochemical Society transactions·2026
Same journal

Mechanisms influencing transient cytoplasmic protein targeting to intracellular lipid droplets.

Biochemical Society transactions·2026
Same journal

Replication associated nuclear DNA mismatch repair across kingdoms.

Biochemical Society transactions·2026
Same journal

Phosphatases of regenerating liver downregulate PTEN to promote tumorigenesis.

Biochemical Society transactions·2026
Same journal

Implications of Rho GTPase signaling in cancer immunotherapy.

Biochemical Society transactions·2026
See all related articles

Cannabinoids, known for anti-inflammatory effects, may also protect nerves by activating peroxisome-proliferator-activated receptors (PPARs). This identifies a new pathway for cannabinoid-based neuroprotective therapies.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Molecular Biology

Background:

  • Cannabinoids exhibit anti-inflammatory and neuroprotective effects.
  • These effects were primarily attributed to cannabinoid receptor 1 (CB1) activation.
  • Emerging evidence suggests cannabinoids also interact with nuclear receptors.

Purpose of the Study:

  • To review the evidence linking cannabinoids to peroxisome-proliferator-activated receptors (PPARs).
  • To explore PPARs as a novel intracellular target for cannabinoid action.
  • To discuss the therapeutic potential of this interaction for neuroprotection.

Main Methods:

  • Literature review of studies investigating cannabinoid-PPAR interactions.
  • Analysis of evidence for cannabinoids acting as ligands for PPARs.

Related Experiment Videos

  • Synthesis of findings regarding the role of PPARs in cannabinoid-mediated neuroprotection.

    • Main Results:

    • Cannabinoids have been identified as ligands for various PPAR subtypes.
    • Activation of PPARs represents a significant intracellular mechanism for cannabinoid effects.
    • This interaction provides a new perspective on the neuroprotective capabilities of cannabinoids.

    Conclusions:

    • Cannabinoid interaction with PPARs offers a novel therapeutic target.
    • Targeting cannabinoid-PPAR pathways may enhance neuroprotective strategies.
    • Further research into this mechanism could lead to new treatments for neurological disorders.